From the FDA.
- Published in:
- 2015
- Publication type:
- Journal Article
Works matching IS 10685308 AND DT 2015 AND VI 26
Results: 133
1
2
Intranasal ketamine shows rapid effects in depression study.
- Published in:
- 2015
- Publication type:
- Journal Article
3
Modest effect from modafinil, armodafinil on schizophrenia symptoms.
- Published in:
- 2015
- Publication type:
- Journal Article
4
Cardiac conduction effects with olanzapine.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
5
From the FDA.
- Published in:
- Brown University Psychopharmacology Update, 2015, v. 26, n. 3, p. 8, doi. 10.1002/pu.30031
- Publication type:
- Article
6
High-dose antipsychotics associated with falls in nursing home patients.
- Published in:
- Brown University Psychopharmacology Update, 2015, v. 26, n. 3, p. 8
- Publication type:
- Article
7
Early results from antidepressant modestly predict later response.
- Published in:
- Brown University Psychopharmacology Update, 2015, v. 26, n. 3, p. 8
- Publication type:
- Article
8
Use of LSD in controlled setting improves illness-related anxiety.
- Published in:
- Brown University Psychopharmacology Update, 2015, v. 26, n. 3, p. 7
- Publication type:
- Article
9
Study offers partial support for curcumin in depression.
- Published in:
- Brown University Psychopharmacology Update, 2015, v. 26, n. 3, p. 7
- Publication type:
- Article
10
Acute psychosis treated successfully with immunotherapy.
- Published in:
- Brown University Psychopharmacology Update, 2015, v. 26, n. 3, p. 7
- Publication type:
- Article
11
Intranasal ketamine shows rapid effects in depression study.
- Published in:
- Brown University Psychopharmacology Update, 2015, v. 26, n. 3, p. 4, doi. 10.1002/pu.30029
- Publication type:
- Article
12
Modest effect from modafinil, armodafinil on schizophrenia symptoms.
- Published in:
- Brown University Psychopharmacology Update, 2015, v. 26, n. 3, p. 3, doi. 10.1002/pu.30028
- Publication type:
- Article
13
Cardiac conduction effects with olanzapine.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
14
Study finds some unendorsed practices in first-episode schizophrenia prescribing.
- Published in:
- Brown University Psychopharmacology Update, 2015, v. 26, n. 3, p. 1, doi. 10.1002/pu.30026
- Publication type:
- Article
15
No exposure to antipsychotics yields greatest mortality risk in schizophrenia.
- Published in:
- Brown University Psychopharmacology Update, 2015, v. 26, n. 3, p. 1, doi. 10.1002/pu.30025
- Publication type:
- Article
16
Clozapine Clozaril.
- Published in:
- Brown University Psychopharmacology Update, 2015, v. 26, p. 1
- Publication type:
- Article
17
From the FDA.
- Published in:
- 2015
- Publication type:
- Journal Article
18
From the FDA.
- Published in:
- Brown University Psychopharmacology Update, 2015, v. 26, n. 2, p. 8, doi. 10.1002/pu.30023
- Publication type:
- Article
19
Antipsychotics most effective for more severe schizophrenia.
- Published in:
- Brown University Psychopharmacology Update, 2015, v. 26, n. 2, p. 8
- Publication type:
- Article
20
Trazodone helps nighttime sleep in patients with Alzheimer's.
- Published in:
- Brown University Psychopharmacology Update, 2015, v. 26, n. 2, p. 8
- Publication type:
- Article
21
Antipsychotic polypharmacy falls short for Medicaid population.
- Published in:
- Brown University Psychopharmacology Update, 2015, v. 26, n. 2, p. 7
- Publication type:
- Article
22
Ketamine injections improve symptoms in treatment-resistant depression.
- Published in:
- Brown University Psychopharmacology Update, 2015, v. 26, n. 2, p. 7
- Publication type:
- Article
23
Escitalopram safe and effective for depression after coronary syndrome.
- Published in:
- Brown University Psychopharmacology Update, 2015, v. 26, n. 2, p. 7
- Publication type:
- Article
24
Pathological gambling, other disorders linked with dopamine agonists.
- Published in:
- Brown University Psychopharmacology Update, 2015, v. 26, n. 2, p. 4, doi. 10.1002/pu.30021
- Publication type:
- Article
25
Research Roundup.
- Published in:
- 2015
- Publication type:
- Journal Article
26
Anticholinergic medications and fractures.
- Published in:
- Brown University Psychopharmacology Update, 2015, v. 26, n. 2, p. 2, doi. 10.1002/pu.30019
- By:
- Publication type:
- Article
27
Gene variant plays role in response to antidepressant.
- Published in:
- Brown University Psychopharmacology Update, 2015, v. 26, n. 1, p. 3, doi. 10.1002/pu.30012
- Publication type:
- Article
28
Adjunctive ECT improves response in clozapine-resistant patients.
- Published in:
- Brown University Psychopharmacology Update, 2015, v. 26, n. 2, p. 1, doi. 10.1002/pu.30018
- Publication type:
- Article
29
Paliperidone Invega.
- Published in:
- Brown University Psychopharmacology Update, 2015, v. 26, p. 1
- Publication type:
- Article
30
Review: Anti-inflammatory treatment improves symptoms of depression.
- Published in:
- Brown University Psychopharmacology Update, 2015, v. 26, n. 2, p. 3, doi. 10.1002/pu.30020
- Publication type:
- Article
31
From the FDA.
- Published in:
- Brown University Psychopharmacology Update, 2015, v. 26, n. 1, p. 8
- Publication type:
- Article
32
Genetic factors predict nonremission in citalopram study.
- Published in:
- Brown University Psychopharmacology Update, 2015, v. 26, n. 1, p. 4, doi. 10.1002/pu.30013
- Publication type:
- Article
33
Depression study of omega-3 effects garners substantial placebo response.
- Published in:
- Brown University Psychopharmacology Update, 2015, v. 26, n. 2, p. 1, doi. 10.1002/pu.30017
- Publication type:
- Article
34
ECT effective compared with medication treatment in bipolar depression.
- Published in:
- Brown University Psychopharmacology Update, 2015, v. 26, n. 1, p. 2, doi. 10.1002/pu.30011
- Publication type:
- Article
35
Research Roundup.
- Published in:
- Brown University Psychopharmacology Update, 2015, v. 26, n. 1, p. 7, doi. 10.1002/pu.30014
- Publication type:
- Article
36
Lifestyle intervention boosts indicators of health in antipsychotic users.
- Published in:
- Brown University Psychopharmacology Update, 2015, v. 26, n. 1, p. 1, doi. 10.1002/pu.30010
- Publication type:
- Article
37
Use of B vitamins improves response to antidepressants over one year.
- Published in:
- Brown University Psychopharmacology Update, 2015, v. 26, n. 1, p. 1, doi. 10.1002/pu.30009
- Publication type:
- Article
38
Vilazodone (generic) VIIBRYD (BRAND).
- Published in:
- Brown University Psychopharmacology Update, 2015, v. 26, p. 1
- Publication type:
- Article
39
From the FDA.
- Published in:
- Brown University Psychopharmacology Update, 2015, v. 26, n. 12, p. 8, doi. 10.1002/pu
- Publication type:
- Article
40
RESEARCH ROUNDUP.
- Published in:
- Brown University Psychopharmacology Update, 2015, v. 26, n. 12, p. 7, doi. 10.1002/pu.30102
- Publication type:
- Article
41
Antidepressants block effect of D-cycloserine in OCD treatment.
- Published in:
- Brown University Psychopharmacology Update, 2015, v. 26, n. 12, p. 4, doi. 10.1002/pu.30101
- Publication type:
- Article
42
Omega-3 fatty acids may prevent long-term progression to psychosis.
- Published in:
- Brown University Psychopharmacology Update, 2015, v. 26, n. 12, p. 3, doi. 10.1002/pu.30100
- Publication type:
- Article
43
Cushing's syndrome with concurrent use of fluvoxamine, budesonide.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
44
Longitudinal study shows no effect of supplements on cognition in elderly.
- Published in:
- Brown University Psychopharmacology Update, 2015, v. 26, n. 12, p. 1, doi. 10.1002/pu.30098
- Publication type:
- Article
45
FDA approves revised prescribing for clozapine; new REMS in effect.
- Published in:
- Brown University Psychopharmacology Update, 2015, v. 26, n. 12, p. 1, doi. 10.1002/pu.30097
- By:
- Publication type:
- Article
46
YOUR MEDICATION INFORMATION.
- Published in:
- Brown University Psychopharmacology Update, 2015, v. 26, p. 1, doi. 10.1002/pu.30016
- Publication type:
- Article
47
From the FDA.
- Published in:
- Brown University Psychopharmacology Update, 2015, v. 26, n. 11, p. 8
- Publication type:
- Article
48
Antidepressants combined with NSAIDs increase risk of intracranial bleeding.
- Published in:
- Brown University Psychopharmacology Update, 2015, v. 26, n. 11, p. 8
- Publication type:
- Article
49
Meta-analysis: High-level evidence lacking in Lewy body dementia treatment.
- Published in:
- Brown University Psychopharmacology Update, 2015, v. 26, n. 11, p. 8
- Publication type:
- Article
50
Naltrexone reduces drug craving in methamphetamine-dependent group.
- Published in:
- Brown University Psychopharmacology Update, 2015, v. 26, n. 11, p. 7
- Publication type:
- Article